2025-07-19 - Analysis Report
Okay, here's a report analyzing Intuitive Surgical Inc (ISRG) based on the data provided.

**Executive Summary**

Intuitive Surgical Inc. (ISRG) is a global technology leader pioneering robotic surgical systems. The stock has outperformed the S&P 500 over the long term, but recent performance indicates potential short-term caution due to various factors including market risk, moving average trends, and hybrid signals suggesting a move towards cash.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** ISRG
*   **Company Name:** Intuitive Surgical Inc.
*   **ISRG Cumulative Return:** 118.60%
*   **VOO Cumulative Return:** 96.72%
*   **Absolute Divergence:** 22.8
*   **Relative Divergence:** 22.0 (This means ISRG's divergence from VOO is currently at the 22nd percentile of its historical range.)

**Analysis:**

ISRG has significantly outperformed the S&P 500 in terms of cumulative return. However, the relative divergence indicates that the outperformance, while still positive, is not at its peak historically.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta | Cap(B) |
|------------|--------|--------|--------|------|--------|
| 2015-2017  | 68.0%  | 56.5%  | 39.0%  | 0.0  | 43.6   |
| 2016-2018  | 77.0%  | 63.4%  | 59.0%  | 0.0  | 57.2   |
| 2017-2019  | 81.0%  | 63.4%  | 52.0%  | 0.3  | 70.6   |
| 2018-2020  | 47.0%  | 63.4%  | 28.0%  | 0.2  | 97.7   |
| 2019-2021  | 91.0%  | 63.0%  | 43.0%  | 0.2  | 128.8  |
| 2020-2022  | -3.0%  | 69.9%  | -6.0%  | 0.2  | 95.1   |
| 2021-2023  | -5.0%  | 72.9%  | -23.0% | 0.9  | 120.9  |
| 2022-2024  | 26.0%  | 72.9%  | 0.0%   | 0.9  | 187.1  |
| 2023-2025  | 39.0%  | 72.9%  | -9.0%  | 0.7  | 185.9  |

**Analysis:**

*   **CAGR:** High growth rates in earlier periods, but more recently, returns have fluctuated, even showing negative CAGR for 2020-2023 and 2021-2023.
*   **MDD:** High Maximum Drawdown (MDD) values indicate significant potential for price drops from peak to trough.  The MDD has remained relatively high in recent periods, suggesting ongoing volatility.
*   **Alpha:**  Alpha represents the excess return compared to a benchmark (likely the S&P 500).  ISRG showed strong positive alpha in earlier periods but has exhibited negative or near-zero alpha more recently.
*   **Beta:** Beta measures volatility relative to the market. Beta values have been consistently low, but recently the value has increased and has approached 1, suggesting increased correlation with overall market movements.
*   **Cap:** Market capitalization has seen growth.

**2. Recent Price Action**

*   **Current Price:** 518.62
*   **Previous Close:** 516.16
*   **Change:** 0.48
*   **5-day Moving Average:** 515.22
*   **20-day Moving Average:** 525.36
*   **60-day Moving Average:** 532.97

**Analysis:**

The stock price is slightly up from the previous close. However, the price is below both the 20-day and 60-day moving averages, which *could* be interpreted as a short-term downward trend. The small price change relative to the previous close suggests no major immediate volatility event, so we do not need to reflect any fluctuation issues.

**3. Technical Indicators & Market Risk**

*   **Market Risk Indicator (MRI):** 0.3399 (Low Risk)
*   **RSI:** 39.54
*   **PPO:** -0.25
*   **Hybrid Signal:** cash_69%_Sell 69.7% of holdings (380 shares - Caution - MRI:0.35)
*   **Recent (20-day) Relative Divergence Change:** -5.7 (Negative - Short-term decline)
*   **Expected Return:** 148.0% (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:** The MRI indicates low market risk.
*   **RSI:** The RSI is below 40, suggesting the stock might be approaching oversold conditions, potentially indicating a buying opportunity, although further confirmation is needed.
*   **PPO:** The negative PPO suggests short-term weakness relative to longer-term trends.
*   **Hybrid Signal:** The hybrid signal's recommendation to significantly reduce holdings and move to a high cash position suggests a cautious outlook. This signal is sensitive to the MRI.
*   **Relative Divergence:** The recent decline in relative divergence supports the idea of short-term underperformance compared to the S&P 500.
*   **Expected Return:** The high expected return suggests analysts believe in ISRG's long-term potential to outperform the S&P 500.

**4. Recent News & Significant Events**

*   **2025-07-17:** ISRG involved in major business developments/regulatory changes/market events.
*   **2025-07-15:** Analysts discussing ISRG's performance in context of industry trends and global economics.
*   **2025-07-16:** ISRG stock showing notable volatility influenced by recent news, earnings, or executive actions.
*   **2025-07-18:** Market experts highlighting risks and opportunities, advising monitoring of news and company announcements.

**Analysis:**

Recent news points to volatility, active analyst discussion, and significant events impacting the company. This suggests the stock is sensitive to news flow and market sentiment.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-04-23 | 1.95 | 2.25 B$  |
| 2024-10-18 | 1.59 | 2.04 B$  |
| 2024-07-19 | 1.48 | 2.01 B$  |
| 2024-04-19 | 1.54 | 1.89 B$  |
| 2025-04-23 | 1.54 | 1.89 B$  |

**Analysis:**

*   The most recent EPS (1.95) shows a higher EPS compared to previous quarters.
*   Revenue shows a general upward trend, indicating growth in the company's sales. The recent increase to 2.25 B$ shows strong performance.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $2.25B    | 64.69%        |
| 2024-12-31   | $2.41B    | 68.04%        |
| 2024-09-30   | $2.04B    | 67.41%        |
| 2024-06-30   | $2.01B    | 68.30%        |
| 2024-03-31   | $1.89B    | 65.87%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
|--------------|-----------|----------|
| 2025-03-31   | $17.11B   | 4.08%    |
| 2024-12-31   | $16.43B   | 4.17%    |
| 2024-09-30   | $15.58B   | 3.63%    |
| 2024-06-30   | $14.71B   | 3.58%    |
| 2024-03-31   | $13.96B   | 3.90%    |

**Analysis:**

*   **Revenue and Profitability:** Revenue has generally been increasing, with a slight dip in the most recent quarter. Profit margins remain very strong, indicating efficient operations.
*   **Capital and Profitability:** Equity has been growing steadily. ROE (Return on Equity) is relatively stable.

**7. Overall Analysis & Conclusion**

Intuitive Surgical (ISRG) demonstrates a strong history of outperforming the market. However, recent indicators suggest a cautious short-term outlook:

*   **Strengths:** High long-term expected return, strong revenue growth, excellent profit margins, a low Market Risk Indicator.
*   **Weaknesses:** Recent underperformance relative to the S&P 500, negative short-term divergence, hybrid signal indicating a move to cash, and technical indicators pointing to potential short-term weakness.
*   **News:** Recent news indicates the stock is volatile and sensitive to market events.
*   **Recommendation:** The hybrid signal's recommendation to reduce holdings to a 69% cash position suggests caution. While the long-term outlook remains positive, investors should closely monitor news, earnings, and technical indicators for potential buying opportunities or confirmation of the short-term downward trend. The company's financials are sound, but market conditions and recent performance indicators warrant a conservative approach. A "hold" or reduced exposure position might be appropriate in the short term, while retaining a long-term bullish perspective.

